VLPNPV 2022 - Virus-Like Particle & Nano-Particle Vaccines covers topics such as:
- VLP Vaccine Manufacturing
- Virus-Like Particle Vaccines
- VLP Platforms as Delivery Systems for Therapeutics, Imaging and Antigen Presentation
- Nano-Particles and Nano-Particulate Vaccines
- Formulation and Stability of VLP and Nano-Particulate Vaccines and Adjuvants
- Structure (non-enveloped, enveloped and synthetic)
- VLP Expression Systems (Baculovirus, Cell Culture, Yeast, Plants)
- Delivery Systems (including Microneedles)
- HepB
- Safety and Regulatory Issues (regulation of expression systems)
- Influenza
- HPV
- Clinical Trials Updates
- Developing VLP Candidates
- Chitosan Particles
- ISCOMs & ISCOMATRIX
- VLPs as Protein Delivery Systems
- Liposomes
- Novel Applications (eg Cell-Free Synthesis)
- VLPs for Drug Delivery
- Particulate-Based Vaccines
- Nanotechnology Approaches (Non-Conventional VLPs)
VLPNPV 2022 - Virus-Like Particle & Nano-Particle Vaccines brings together researchers/contributors from academic programmes, industrial, governmental and regulatory groups.
